146 related articles for article (PubMed ID: 18180123)
1. Isoprostanes in dystrophinopathy: Evidence of increased oxidative stress.
Grosso S; Perrone S; Longini M; Bruno C; Minetti C; Gazzolo D; Balestri P; Buonocore G
Brain Dev; 2008 Jun; 30(6):391-5. PubMed ID: 18180123
[TBL] [Abstract][Full Text] [Related]
2. Valley sign in Becker muscular dystrophy and outliers of Duchenne and Becker muscular dystrophy.
Pradhan S
Neurol India; 2004 Jun; 52(2):203-5. PubMed ID: 15269471
[TBL] [Abstract][Full Text] [Related]
3. [Isoprostanes--new possibility of the oxidative stress estimation].
Dołegowska B; Chlubek D
Przegl Lek; 2004; 61(12):1410-4. PubMed ID: 15850339
[TBL] [Abstract][Full Text] [Related]
4. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part II. Electromyographic pattern in Becker muscular dystrophy in comparison with Duchenne muscular dystrophy.
Emeryk-Szajewska B; Kopeć J
Electromyogr Clin Neurophysiol; 2008; 48(6-7):279-84. PubMed ID: 18837193
[TBL] [Abstract][Full Text] [Related]
5. Evolution of gastric electrical features and gastric emptying in children with Duchenne and Becker muscular dystrophy.
Borrelli O; Salvia G; Mancini V; Santoro L; Tagliente F; Romeo EF; Cucchiara S
Am J Gastroenterol; 2005 Mar; 100(3):695-702. PubMed ID: 15743370
[TBL] [Abstract][Full Text] [Related]
6. [Cardiologic study of 10 patients with Duchenne muscular dystrophy(DMD): personal experience].
Falsaperla R; Romeo G; Sciacca P; Di Giorgio A; Mattia CL; Distefano G
Pediatr Med Chir; 2001; 23(1):57-60. PubMed ID: 11486424
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase in muscular dystrophies: a re-evaluation.
Buchwalow IB; Minin EA; Müller FU; Lewin G; Samoilova VE; Schmitz W; Wellner M; Hasselblatt M; Punkt K; Müller-Werdan U; Demus U; Slezak J; Koehler G; Boecker W
Acta Neuropathol; 2006 Jun; 111(6):579-88. PubMed ID: 16718354
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of vascular endothelial growth factor elevated in patients with muscular dystrophy.
Saito T; Yamamoto Y; Matsumura T; Fujimura H; Shinno S
Brain Dev; 2009 Sep; 31(8):612-7. PubMed ID: 18980821
[TBL] [Abstract][Full Text] [Related]
9. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
[TBL] [Abstract][Full Text] [Related]
10. Serum isoprostanes levels in patients after abdominal hysterectomy.
Szymczyk G; Bełtowski J; Marciniak A; Kotarski J
Rocz Akad Med Bialymst; 2005; 50():322-4. PubMed ID: 16358993
[TBL] [Abstract][Full Text] [Related]
11. Serum myoglobin in muscular dystrophy.
Kagen LJ; Moussavi S; Miller SL; Tsairis P
Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
[TBL] [Abstract][Full Text] [Related]
12. Circulating markers of oxidative stress are associated with a muscle injury in patients with muscular dystrophy Duchenne.
Almeida-Becerril T; Rodríguez-Cruz M; Raúl Sánchez-González J; Antonio Villaldama-Soriano M; Atilano-Miguel S; Villa-Morales J; Cárdenas-Conejo A; Cárdenas-Vázquez R
Brain Dev; 2021 Jan; 43(1):111-120. PubMed ID: 32654955
[TBL] [Abstract][Full Text] [Related]
13. Comparison of serum F2 isoprostane levels in diabetic patients and diabetic patients infected with Burkholderia pseudomallei.
Puthucheary SD; Nathan SA
Singapore Med J; 2008 Feb; 49(2):117-20. PubMed ID: 18301838
[TBL] [Abstract][Full Text] [Related]
14. Decreased calcineurin activity in circulation of Duchenne muscular dystrophy.
Sundaram JS; Rao VM; Meena AK; Anandaraj MP
Clin Biochem; 2007 Apr; 40(7):443-6. PubMed ID: 17328882
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
[TBL] [Abstract][Full Text] [Related]
16. Endomysial fibrosis in Duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation.
Desguerre I; Mayer M; Leturcq F; Barbet JP; Gherardi RK; Christov C
J Neuropathol Exp Neurol; 2009 Jul; 68(7):762-73. PubMed ID: 19535995
[TBL] [Abstract][Full Text] [Related]
17. Bone mass development in patients with Duchenne and Becker muscular dystrophies: a 4-year clinical follow-up.
Söderpalm AC; Magnusson P; Åhlander AC; Karlsson J; Kroksmark AK; Tulinius M; Swolin-Eide D
Acta Paediatr; 2012 Apr; 101(4):424-32. PubMed ID: 22103559
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of plasma lipid abnormalities in human and canine Duchenne and Becker muscular dystrophies depicts a new type of primary genetic dyslipidemia.
White Z; Hakim CH; Theret M; Yang NN; Rossi F; Cox D; Francis GA; Straub V; Selby K; Panagiotopoulos C; Duan D; Bernatchez P
J Clin Lipidol; 2020; 14(4):459-469.e0. PubMed ID: 32593511
[TBL] [Abstract][Full Text] [Related]
19. [Combining approach with multiplex PCR and MLPA to detect deletion and duplication in DMD patients, carriers, and prenatal diagnosis].
Li H; Ding J; Wang W; Chen Y; Lu W; Shao H; Wu BL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun; 26(3):318-22. PubMed ID: 19504448
[TBL] [Abstract][Full Text] [Related]
20. Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats.
Roberts LJ; Reckelhoff JF
Biochem Biophys Res Commun; 2001 Sep; 287(1):254-6. PubMed ID: 11549283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
